Allosteric inhibition of SHP2 phosphatase inhibits cancers driven by receptor tyrosine kinasesYing-Nan P. Chen, Nicholas Keen, Brandon Antonakos et al.|Nature|2016Cited by 925
TMEM41B is a novel regulator of autophagy and lipid mobilizationFrancesca Moretti, Beat Nyfeler, Phil Bergman et al.|EMBO Reports|2018Cited by 178
An iron-dependent metabolic vulnerability underlies VPS34-dependence in RKO cancer cellsMarek J. Kobylarz, Beat Nyfeler, Jonathan M. Goodwin et al.|PLoS ONE|2020Cited by 13